Table 1.
The Co-Expression Analysis for miR-186 and targets (from ENCORI database)
| Correlation | Cancer Types | Sample Num. | Coefficient -r |
p-value |
|---|---|---|---|---|
| miR-186 VS PTEN | Breast Invasive Carcinoma | 1085 | -0.172 | 1.17E-08 |
| Colon Adenocarcinoma | 450 | -0.112 | 1.80E-02 | |
| Liver Hepatocellular Carcinoma | 370 | -0.11 | 3.42E-02 | |
| Lung Adenocarcinoma | 512 | -0.161 | 2.64E-04 | |
| Lung Squamous Cell Carcinoma | 475 | -0.096 | 3.68E-02 | |
| Head and Neck Squamous Cell Carcinoma | 497 | -0.103 | 2.15E-02 | |
| Kidney Renal Papillary Cell Carcinoma | 289 | -0.300 | 1.98E-07 | |
| Bladder Urothelial Carcinoma | 408 | -0.227 | 3.71E-06 | |
| Acute Myeloid Leukemia | 83 | -0.308 | 4.67E-03 | |
| Brain Lower Grade Glioma | 525 | -0.093 | 3.36E-02 | |
| Pheochromocytoma and Paraganglioma | 183 | -0.308 | 2.26E-05 | |
| Rectum Adenocarcinoma | 161 | -0.302 | 9.82E-05 | |
| Stomach Adenocarcinoma | 372 | -0.256 | 5.62E-07 | |
| Uterine Corpus Endometrial Carcinoma | 538 | -0.145 | 7.17E-04 | |
| miR-186 VS PIK3R3 | Testicular Germ Cell Tumors | 156 | -0.318 | 5.35E-05 |
| Thymoma | 119 | -0.305 | 7.31E-04 | |
| Kidney Renal Clear Cell Carcinoma | 517 | -0.092 | 3.70E-02 | |
| miR-186 VS APAF1 | Liver Hepatocellular Carcinoma | 370 | 0.146 | 4.84E-03 |
| Esophageal Carcinoma | 162 | 0.189 | 1.61E-02 | |
| Kidney Renal Clear Cell Carcinoma | 517 | 0.096 | 2.96E-02 | |
| Skin Cutaneous Melanoma | 449 | 0.242 | 2.10E-07 | |
| Stomach Adenocarcinoma | 372 | 0.111 | 3.17E-02 |